Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Neuronavigated Theta-Burst Transcranial Magnetic Stimulation (TBS) for Early Alzheimer's Disease

NCT06524817 is registered in ClinicalTrials.gov with Anhui Medical University as lead sponsor.

NCT NCT06524817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06524817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Neuronavigated Theta-Burst Transcranial Magnetic Stimulation (TBS) for Early Alzheimer's Disease
Lead sponsor
Anhui Medical University
Phase
Not applicable
Overall status
Withdrawn
Start date
September 10, 2023
Completion date
March 10, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, neuronavigation, transcranial magnetic stimulation